Skip to main content Accessibility help
×
Home
Hostname: page-component-888d5979f-t46fd Total loading time: 2.586 Render date: 2021-10-25T19:30:43.247Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Zonisamide

Published online by Cambridge University Press:  01 June 2018

Philip N. Patsalos
Affiliation:
UCL Institute for Neurology
Erik K. St Louis
Affiliation:
Mayo Clinic
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ando, H, Matsubara, S, Oi, A, Usai, R, Suzuki, M, Fujimuru, A. Two nursing mothers treated with zonisamide: should breast feeding be avoided? Journal of Obstetrics and Gynaecological Research 2014; 40: 275278.CrossRefGoogle ScholarPubMed
Brackett, CC, Singh, H, Block, JH. Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group. Pharmacotherapy 2004; 24: 856870.CrossRefGoogle ScholarPubMed
Brodie, MJ, Duncan, R, Vespignani, H, Solyom, A, Bitenskyy, V, Lucas, C. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. Epilepsia 2005; 46: 3141.Google ScholarPubMed
Faught, E, Ayala, R, Montouris, GG, Leppik, IE. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001; 57: 17741779.CrossRefGoogle ScholarPubMed
Glauser, TA, Pellock, JM. Zonisamide in pediatric epileps: review of the Japanese literature. Journal of Child Neurology 2002; 17: 8796.CrossRefGoogle Scholar
Kim, HL, Aldridge, J, Rho, JM. Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center. Journal of Child Neurology 2005; 20: 212219.CrossRefGoogle Scholar
Kyllerman, M, Ben-Menachem, E. Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients. Epilepsy Research 1998; 29: 109114.CrossRefGoogle ScholarPubMed
Leppik, IE. Practical prescribing and long-term efficacy and safety of zonisamide. Epilepsy Research 2006; 68S; S17S24.CrossRefGoogle Scholar
Low, PA, James, S, Peschel, T, Leong, R, Rothstein, A. Zonisamide and associated oligohydrosis and hyperthermia. Epilepsy Research 2004; 62: 2734.CrossRefGoogle Scholar
Mimaki, T. Clinical pharmacology and therapeutic drug monitoring of zonisamide. Therapeutic Drug Monitoring 1998; 29: 593597.CrossRefGoogle Scholar
Patsalos, PN. Antiepileptic drug interactions: a clinical guide, 3rd edition. Springer, London, UK; 2016.CrossRefGoogle Scholar
Patsalos, PN, Zugman, M, Lake, C, James, A, Ratnaraj, N, Sander, JW. Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: a comparison of free non-protein-bound concentrations. Epilepsia 2017; 58: 12341243.CrossRefGoogle Scholar
St. Louis, EK, Gidal, BE, Henry, TR, Kaydanova, Y, Krumholz, A, McCabe, PH, Montouris, GD, Rosenfeld, WE, Smith, BJ, Stern, JM, Waterhouse, EJ, Schulz, RM, Garnett, WR, Bramley, T. Conversions between monotherapies in epilepsy: expert consensus. Epilepsy and Behavior 2007; 11: 222234.CrossRefGoogle ScholarPubMed
Suzuki, Y, Imai, K, Toribe, Y, Ueda, H, Yanagihara, K, Shimono, K, Okinaga, T, Ono, J, Nagai, T, Matsuoka, T, Tagawa, T, Abe, J, Morita, Y, Fujikawa, Y, Arai, H, Mano, T, Okada, S. Long-term response to zonisamide in patients with West syndrome. Neurology 2002; 58: 15561559.CrossRefGoogle ScholarPubMed
Suzuki, Y, Nagai, T, Ono, J, Imai, K, Otani, K, Tagawa, T, Abe, J, Shiomi, M, Okada, S. Zonisamide monotherapy in newly diagnosed infantile spasms. Epilepsia 1997; 38: 10351038.CrossRefGoogle ScholarPubMed
Wallander, KM, Ohman, I, Dahlin, M. Zonisamide: pharmacokinetics, efficacy and adverse events in children with epilepsy. Neuropediatrics 2014; 45: 362369.Google ScholarPubMed
Weston, J, Bromley, R, Jackson, CF, Adab, N, Clayton-Smith, L, Greenhalgh, J, Hounsome, J, McKay, AJ, Tudor Smith, C, Marson, AG. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Systematic Review 2016; 11: CD010224.Google ScholarPubMed

Send book to Kindle

To send this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Send book to Dropbox

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Dropbox.

Available formats
×

Send book to Google Drive

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Google Drive.

Available formats
×